• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂霉素C:一种原型生物还原剂。

Mitomycin C: a prototype bioreductive agent.

作者信息

Sartorelli A C, Hodnick W F, Belcourt M F, Tomasz M, Haffty B, Fischer J J, Rockwell S

机构信息

Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Oncol Res. 1994;6(10-11):501-8.

PMID:7620218
Abstract

Hypoxic cells of solid tumors represent a therapeutically resistant population that limits the curability of many solid tumors by x-irradiation and by most chemotherapeutic agents. The oxygen deficit, however, creates an environment conducive to reductive processes that results in a major exploitable difference between normal and neoplastic tissues. Mitomycin C (MC) can be reductively activated by a number of oxidoreductases, in a process required for the production of its therapeutic effects. This enzymatic reduction results in preferential activation of MC under hypoxia and, in most instances, the production of greater toxicity to oxygen-deficient cells than to their oxygenated counterparts. DNA appears to be the most important target of the reactive species generated from MC, with both mono- and bis-adducts of DNA being formed in drug-treated cells. The demonstration that MC, used to kill the hypoxic fraction, in combination with x-irradiation, to eradicate the oxygenated portion of the tumor, produced enhanced cytodestructive effects on solid tumors of animals has led to the clinical evaluation of the mitomycin antibiotics in combination with x-rays in patients with cancers of the head and neck. The findings from these clinical trials have demonstrated the utility of directing a concerted therapeutic attack on the hypoxic fraction of solid tumors as an approach toward enhancing the curability of localized neoplasms by x-irradiation.

摘要

实体瘤中的缺氧细胞代表了一个具有治疗抗性的群体,它限制了许多实体瘤通过X射线照射和大多数化疗药物治愈的可能性。然而,缺氧环境创造了有利于还原过程的条件,这导致了正常组织和肿瘤组织之间存在一个主要的可利用差异。丝裂霉素C(MC)可以被多种氧化还原酶还原激活,这是其产生治疗效果所必需的过程。这种酶促还原导致MC在缺氧条件下优先被激活,并且在大多数情况下,对缺氧细胞产生的毒性比对其富氧对应细胞更大。DNA似乎是MC产生的反应性物种的最重要靶点,在药物处理的细胞中会形成DNA的单加合物和双加合物。有证据表明,用于杀死缺氧部分的MC与X射线照射联合使用,以根除肿瘤的富氧部分,对动物实体瘤产生了增强的细胞破坏作用,这促使人们对丝裂霉素类抗生素与X射线联合用于头颈癌患者进行临床评估。这些临床试验的结果表明,针对实体瘤的缺氧部分进行协同治疗攻击,作为一种通过X射线照射提高局部肿瘤治愈率的方法是有用的。

相似文献

1
Mitomycin C: a prototype bioreductive agent.丝裂霉素C:一种原型生物还原剂。
Oncol Res. 1994;6(10-11):501-8.
2
Preferential kill of hypoxic EMT6 mammary tumor cells by the bioreductive alkylating agent porfiromycin.生物还原烷化剂卟吩姆对缺氧的EMT6乳腺肿瘤细胞的选择性杀伤作用。
Adv Enzyme Regul. 1995;35:117-30. doi: 10.1016/0065-2571(94)00015-u.
3
Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.缺氧肿瘤细胞对丝裂霉素C向细胞毒性代谢物的优先激活作用。
Cancer Res. 1980 Jul;40(7):2356-60.
4
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.在用丝裂霉素C处理的EMT6小鼠乳腺肿瘤细胞中丝裂霉素代谢物2,7-二氨基丝裂霉素主要DNA加合物的形成。
Oncol Res. 1998;10(10):509-21.
5
Therapeutic attack of hypoxic cells of solid tumors: presidential address.实体瘤缺氧细胞的治疗性攻击:主席致辞
Cancer Res. 1988 Feb 15;48(4):775-8.
6
Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.丝裂霉素C与EMT6小鼠乳腺肿瘤细胞中DNA的加合物:缺氧和双香豆素对加合物模式的影响
Cancer Res. 1993 Nov 1;53(21):5127-34.
7
Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.丝裂霉素与DNA之间单烷基化产物的细胞毒性潜力:野生型和修复缺陷细胞系中去甲氨甲酰基丝裂霉素C的研究
Oncol Res. 1995;7(5):39-47.
8
Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.双香豆素在体内外增强丝裂霉素C对缺氧肿瘤细胞的细胞毒性作用。
Cancer Res. 1985 Jan;45(1):213-6.
9
Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells.通过在中国仓鼠卵巢细胞中过表达生物还原酶逆转丝裂霉素C耐药性
Cancer Res. 2001 Nov 1;61(21):7770-6.
10
Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.丝裂霉素与DNA之间单烷基化产物的细胞毒性潜力:野生型和修复缺陷细胞系中去甲氨甲酰基丝裂霉素C的研究
Oncol Res. 1995;7(1):39-47.

引用本文的文献

1
Therapeutic Effect of Regional Chemotherapy in Diffuse Metastatic Cholangiocarcinoma.区域化疗在弥漫性转移性胆管癌中的治疗效果
Cancers (Basel). 2022 Jul 29;14(15):3701. doi: 10.3390/cancers14153701.
2
Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumors.米托蒽醌脂质体前药在人肿瘤中的体外激活。
Cancer Chemother Pharmacol. 2022 Aug;90(2):109-114. doi: 10.1007/s00280-022-04451-1. Epub 2022 Jul 8.
3
The dietary triterpenoid 18α-Glycyrrhetinic acid protects from MMC-induced genotoxicity through the ERK/Nrf2 pathway.
膳食三萜 18α-甘草次酸通过 ERK/Nrf2 通路防止 MMC 诱导的遗传毒性。
Redox Biol. 2020 Jan;28:101317. doi: 10.1016/j.redox.2019.101317. Epub 2019 Sep 3.
4
Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection.人组织工程化骨骼肌:一种新型的肌肉内注射后药物处置和毒性的 3D 体外模型。
Sci Rep. 2018 Aug 15;8(1):12206. doi: 10.1038/s41598-018-30123-3.
5
Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21WAF1/CIP1 activation.丝裂霉素C和去氨甲酰基丝裂霉素C诱导不依赖p53的p21WAF1/CIP1激活。
Int J Oncol. 2016 Nov;49(5):1815-1824. doi: 10.3892/ijo.2016.3703. Epub 2016 Sep 23.
6
Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues.丝裂霉素C聚乙二醇化脂质体前药(Promitil(®))的药理学研究:在血浆中高度稳定,在组织中快速硫解前药活化。
Pharm Res. 2016 Mar;33(3):686-700. doi: 10.1007/s11095-015-1819-7. Epub 2015 Nov 16.
7
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients.聚乙二醇化脂质体丝裂霉素C前药增强了丝裂霉素C的耐受性:一项针对晚期实体瘤患者的1期研究。
Cancer Med. 2015 Oct;4(10):1472-83. doi: 10.1002/cam4.491. Epub 2015 Jul 14.
8
The Generation and Reactions of Quinone Methides.醌甲基化物的生成与反应
Adv Phys Org Chem. 2011 Jan 1;45:39-91. doi: 10.1016/B978-0-12-386047-7.00002-3.
9
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors.缺氧可调节一系列临床批准的酪氨酸激酶抑制剂的活性。
Br J Pharmacol. 2014 Jan;171(1):224-36. doi: 10.1111/bph.12438.
10
Enhancement of the efficacy of mitomycin C-mediated apoptosis in human colon cancer cells with RNAi-based thioredoxin reductase 1 deficiency.基于RNA干扰的硫氧还蛋白还原酶1缺陷增强丝裂霉素C介导的人结肠癌细胞凋亡的疗效
Exp Ther Med. 2011 Sep;2(5):873-878. doi: 10.3892/etm.2011.304. Epub 2011 Jun 30.